Knight Therapeutics Inc. (04K)
FSX
Closed
Aug 25, 2026
Day's Range
5.9552 wk Range
3.46Overview - 04K - Knight Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
309.27M
P/E (Trailing)
‪66.11‬
PEG Ratio
‪-0.26‬
Price / Sales (TTM)
‪1.06‬
Price / Book
‪1.17‬
EV / EBITDA
‪6.13‬
Profitability
Gross Margin
‪48.27%‬
Profit Margin
‪2.71%‬
Operating Margin
‪6.21%‬
Return on Assets
‪1.31%‬
Return on Equity
‪1.90%‬
Ownership
Shares Outstanding
98.22M
Float
60.29M
Held by Insiders
‪46.99%‬
Held by Institutions
‪18.12%‬
Price stats
Beta
‪0.04‬
50-Day Avg
‪5.94‬
200-Day Avg
‪4.64‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 04K - Knight Therapeutics Inc.
Peers - 04K - Knight Therapeutics Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
Profile Summary - 04K - Knight Therapeutics Inc.
About
Knight Therapeutics Inc. is a Canadian-based specialty pharmaceutical company. Its core purpose is to develop, acquire, license, and deliver innovative pharmaceutical products to fulfill unmet medical needs. The company places a strong emphasis on the therapeutic fields of oncology, infectious diseases, and select…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
